Christopher M Cielo1, Patricia Hernandez2, Alyssa M Ciampaglia3, Melissa S Xanthopoulos4, Suzanne E Beck5, Ignacio E Tapia5. 1. Division of Pulmonary & Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: cieloc@email.chop.edu. 2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 3. Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA. 4. Division of Pulmonary & Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, PA. 5. Division of Pulmonary & Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Abstract
BACKGROUND: Positive airway pressure (PAP) is a standard therapy for the treatment of OSA in children, but objective data on the effectiveness of PAP in infants are sparse. The aim of this study was to compare the effectiveness of PAP in infants younger than 6 months of age with that in school-aged children. RESEARCH QUESTION: Compared with PAP in school-aged children, can PAP be titrated as successfully in infants, and is adherence to PAP similar in both age groups? STUDY DESIGN AND METHODS: Single-center retrospective study. For consecutive infants younger than 6 months of age and school-aged children 5 to 10 years of age with OSA treated with PAP, baseline and titration polysomnography data, PAP adherence data, and parent-reported barriers to adherence were compared between groups. RESULTS: Forty-one infants and 109 school-aged children were included. Median obstructive apnea hypopnea index (OAHI) in infants was 25.7/h (interquartile range [IQR], 17.8-35.9/h) and was greater than that in school-aged children (12.1/hr; IQR, 7.6-21.5/h; P < .0001). After PAP titration, OAHI was reduced by a median of 92.1% in infants, similar to the median 93.4% reduction in school-aged children (P = .67). PAP was used in infants on 94.7% of nights, which was more than the 83% in school-aged children (P = .003). No differences were found in barriers to adherence between infants and school-aged children, with behavioral barriers being most common in both groups. INTERPRETATION: Objective data demonstrate that PAP is both highly effective at treating OSA and well-tolerated in infants. Like older patients, PAP should be considered along with other therapies for the treatment of OSA in even the youngest children.
BACKGROUND: Positive airway pressure (PAP) is a standard therapy for the treatment of OSA in children, but objective data on the effectiveness of PAP in infants are sparse. The aim of this study was to compare the effectiveness of PAP in infants younger than 6 months of age with that in school-aged children. RESEARCH QUESTION: Compared with PAP in school-aged children, can PAP be titrated as successfully in infants, and is adherence to PAP similar in both age groups? STUDY DESIGN AND METHODS: Single-center retrospective study. For consecutive infants younger than 6 months of age and school-aged children 5 to 10 years of age with OSA treated with PAP, baseline and titration polysomnography data, PAP adherence data, and parent-reported barriers to adherence were compared between groups. RESULTS: Forty-one infants and 109 school-aged children were included. Median obstructive apnea hypopnea index (OAHI) in infants was 25.7/h (interquartile range [IQR], 17.8-35.9/h) and was greater than that in school-aged children (12.1/hr; IQR, 7.6-21.5/h; P < .0001). After PAP titration, OAHI was reduced by a median of 92.1% in infants, similar to the median 93.4% reduction in school-aged children (P = .67). PAP was used in infants on 94.7% of nights, which was more than the 83% in school-aged children (P = .003). No differences were found in barriers to adherence between infants and school-aged children, with behavioral barriers being most common in both groups. INTERPRETATION: Objective data demonstrate that PAP is both highly effective at treating OSA and well-tolerated in infants. Like older patients, PAP should be considered along with other therapies for the treatment of OSA in even the youngest children.
Authors: Maria Pia Villa; Jacopo Pagani; Rosa Ambrosio; Roberto Ronchetti; Edoardo Bernkopf Journal: Am J Respir Crit Care Med Date: 2002-10-15 Impact factor: 21.405
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Christopher M Cielo; Kelly A Duffy; Jesse A Taylor; Carole L Marcus; Jennifer M Kalish Journal: J Clin Sleep Med Date: 2019-03-15 Impact factor: 4.062
Authors: Carole L Marcus; Lee Jay Brooks; Kari A Draper; David Gozal; Ann Carol Halbower; Jacqueline Jones; Michael S Schechter; Stephen Howard Sheldon; Karen Spruyt; Sally Davidson Ward; Christopher Lehmann; Richard N Shiffman Journal: Pediatrics Date: 2012-08-27 Impact factor: 7.124
Authors: Prabhjot K Bedi; Maria Luisa Castro-Codesal; Robin Featherstone; Mohammed M AlBalawi; Bashar Alkhaledi; Anita L Kozyrskyj; Carlos Flores-Mir; Joanna E MacLean Journal: Front Pediatr Date: 2018-02-12 Impact factor: 3.418
Authors: Louella Amos; Olufunke Afolabi-Brown; Dominic Gault; Robin Lloyd; Moshe Y Prero; Carol L Rosen; Raman K Malhotra; Jennifer L Martin; Kannan Ramar; James A Rowley; Fariha Abbasi-Feinberg; R Nisha Aurora; Vishesh K Kapur; Uzma Kazmi; David Kuhlmann; Eric J Olson; Anita V Shelgikar; Sherene M Thomas; Lynn Marie Trotti Journal: J Clin Sleep Med Date: 2022-08-01 Impact factor: 4.324
Authors: Po-Yang Tsou; Christopher M Cielo; Melissa S Xanthopoulos; Yu-Hsun Wang; Pei-Lun Kuo; Ignacio E Tapia Journal: Sleep Med Date: 2021-04-16 Impact factor: 4.842
Authors: Indira Chandrasekar; Mary Anne Tablizo; Manisha Witmans; Jose Maria Cruz; Marcus Cummins; Wendy Estrellado-Cruz Journal: Children (Basel) Date: 2022-03-15